MAPK8 and pancreatic neoplasm: We next examined the combination therapy of JNK-in-IX and the standard chemotherapeutic regimen for human pancreatic cancer cell lines, FOLFIRINOX and Gemcitabine-Paclitaxel (Gem-Pac).